Abstract
Objective: To assess the efficacy of the BISAP score in predicting the severity of acute pancreatitis. Study Design: Cross Sectional, Retrospective. Setting: Surgical Unit, Mardan Medical Complex, KPK. Period: June 2022 to October 2024. Methods: A sample size of 192 was determined. The study included patients aged 18-60 years, of both genders, diagnosed with acute pancreatitis based on the American Pancreatic Association criteria. Data was collected using a standardized form and analyzed with SPSS version 22. Results: Among the 192 patients, males and females’ ratio was 1.4: 1. with mean age of 35.89 ± 13.39 years. 31.2% had severe acute pancreatitis (score >3), while 68.75% had mild pancreatitis (p value < 0.001). The area under curve was 0.98, indicating strong diagnostic power. The study had a sensitivity 96.67%, specificity 93.2%, positive likelihood ratio (PPV) 86.6%, and true negative rate (NPV) of 98.43%. Overall diagnostic effectiveness for severity and mortality was 94.3% and 80.7%, respectively. Conclusion: The BISAP score is reliable, rapid, and cost-effective means for assessing severity, enabling effective patient stratification and prompt initiation of intensive management of severe patients to reduce mortality and morbidity.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call